Events

Upcoming Events ¦ Past Events ¦ Scientific Presentations

Upcoming Presentations

Stifel Nicolaus Weisel Annual Healthcare Conference
September 16, 2010, 10:55 a.m. (ET)
Boston, MA

Oppenheimer 21st Annual Healthcare Conference
November 2-3, 2010
New York, NY

2010 Healthcare Conference and Industry Presentations

Canaccord Genuity 30th Annual Growth Conference
Tuesday, August 10, 2010, 4:00 p.m. (ET)
Boston, MA

The Xconomy Summit - XSITE 2010
Panel: When One Product Won’t Cut it: The Return of Biotech Platforms
June 17, 2010
Babson College

BIO 2010 - Panel: Challenging the Conventional Wisdom; Re-emergence of Innovative Chemistry for Breakthrough Drugs
Wednesday, May 5, 2010, 4:00 p.m. (CT)
Chicago, IL

Cowen and Company 30th Annual Health Care Conference
Monday, March 8, 2010, 2:00 p.m. (ET)
Boston, MA

J.P. Morgan 28th Annual Healtcare Conference
Monday, January 11, 2010, 9:00 a.m. (PT)
San Francisco, CA

2009 Healthcare Conference Presentations
Merriman Curhan Ford & Co. 6th Annual Investor Summit 2009
Private Company Panel
Tuesday, November 10, 2009, 2:00 p.m. (ET)
New York, NY

2009 Boston Biotech R&D Conference
Tuesday, October 27, 2009, 1:40 p.m. (ET)
Boston, MA

Thomas Weisel Partners 2009 Healthcare Conefrence
Thursday, September 10, 2009, 10:55 a.m. (ET)
Boston, MA

30th Annual Goldman Sachs Global Healthcare Conference
Private Company Forum
Monday, June 8, 2009, 3:30 p.m. (ET)
New York, NY

Cowen and Company 29th Annual Healthcare Conference
Monday, March 16, 2009, 11:00 a.m. (ET)
Boston, MA

J.P. Morgan 27th Annual Healthcare Conference
Monday, January 12, 2009, 2:00 p.m. (PT)
San Francisco, CA

[ back to top ]

2010 Scientific Presentations

Improvements in Metabolic Stability and Pharmacokinetic Properties with Deuterium-labeling of Drug Candidates
Gordon Research Conference
July 15, 2010

Design and Synthesis of Deuterated Vicriviroc Analogs with Enhanced Metabolic Stability
32nd National Medicinal Chemistry Symposium
June 6-9, 2010

2009 Scientific Presentations
CTP-347: A Deuterated Analog of Paroxetine with Greatly Reduced CYP2D6 Mechanism-Based Inactivation
ISSX 16th North American Regional Meeting
October 18-22, 2009

CTP-347, A Deuterated Paroxetine Analog, Exhibits Reduced Mechanism-Based Inactivation of CYP2D6 in Healthy Women
American College of Clinical Pharmacology’s 38th Annual Meeting
September 13-15, 2009

[ back to top ]